Skip to content
10-Q/A

Quarterly Report

CURATIVE BIOSCIENCES, INC.

0001493152-18-000550

← back to feed
Filed
Jan 16, 2018 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jun 11, 2017 15.71M sh
Operating Cash Flow Q2 2017 · Dec 31, 2016 −$9.11K
Operating Cash Flow Q2 2017 · Dec 31, 2015 −$18.53K
Stockholders Equity Q2 2017 · Dec 31, 2016 −$608.91K
Stockholders Equity Q2 2017 · Jun 30, 2016 −$615.11K
Current Liabilities Q2 2017 · Dec 31, 2016 $612.6K
Current Liabilities Q2 2017 · Jun 30, 2016 $620.22K
Total Liabilities Q2 2017 · Dec 31, 2016 $612.6K
Total Liabilities Q2 2017 · Jun 30, 2016 $620.22K
Total Assets Q2 2017 · Dec 31, 2016 $3.69K
Total Assets Q2 2017 · Jun 30, 2016 $5.11K
Net Income Q2 2017 · Dec 31, 2016 $6.79K
Net Income restated Q2 2017 · Dec 31, 2016 −$31.3K
Net Income restated Q2 2017 · Dec 31, 2015 $1.1M
Net Income Q2 2017 · Dec 31, 2015 −$1.61M
Operating Income Q2 2017 · Dec 31, 2016 $6.79K
Operating Income restated Q2 2017 · Dec 31, 2016 −$31.3K
Operating Income restated Q2 2017 · Dec 31, 2015 $1.1M
Operating Income Q2 2017 · Dec 31, 2015 −$1.61M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $2K
Cash And Equivalents Q2 2017 · Jun 30, 2015 $2K